A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion.

Abstract

This assay is designed to specifically report on HIV-1 fusion via the expression of green fluorescent protein (GFP) detectable by flow cytometry or fluorescence microscopy. An HIV-1 reporter virus (HIV-1 Gag-iCre) is generated by inserting Cre recombinase into the HIV-1 genome between the matrix and the capsid proteins of the Gag polyprotein. This results in a packaging of Cre recombinase into virus particles, which is then released into a target cell line stably expressing a Cre recombinase-activated red fluorescent protein (RFP) to GFP switch cassette. In the basal state, this cassette expresses RFP only. Following the delivery of Cre recombinase into the target cell, the RFP, flanked by loxP sites, excises, resulting in GFP expression. This assay can be used to test any inhibitors of viral entry (specifically at the fusion step) in cell-free and cell-to-cell infection systems and has been used to identify a class of purinergic receptor antagonists as novel inhibitors of HIV-1 viral membrane fusion.

• Authors: Anthony M Esposito, Alexandra Y Soare, Foramben Patel, Namita Satija, Benjamin K Chen, Talia H Swartz
• Journal: Journal of visualized experiments : JoVE (J Vis Exp) Issue 138 (08 14 2018) ISSN: 1940-087X [Electronic] United States
• PMID: 30176017 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Video-Audio Media)

Chemical References

• Cre recombinase
• Integrases

Topics

• Cell Line
• HIV-1 (genetics)
• Humans
• Integrases (genetics)
• Transfection
• Virion